ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 1 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $3,281,000 | 0.46% |
| Northeast Financial Consultants Inc | 577,262 | $358,000 | 0.05% |
| Founders Capital Management | 7,000 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 186,254 | $115,000 | 0.00% |
| A.R.T. Advisors, LLC | 13,455 | $8,000 | 0.00% |
| WILLIAMS JONES & ASSOCIATES LLC | 30,100 | $19,000 | 0.00% |
| Creative Planning | 200,189 | $124,000 | 0.00% |
| GLENMEDE TRUST CO NA | 4 | $0 | 0.00% |
| IFP Advisors, Inc | 1,518 | $1,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,552 | $962,000 | 0.00% |